Compare RNG & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNG | MMSI |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2013 | 1996 |
| Metric | RNG | MMSI |
|---|---|---|
| Price | $38.61 | $66.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $33.58 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 1.4M | 662.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | ★ 176.19 | 4.93 |
| EPS | 0.35 | ★ 0.68 |
| Revenue | ★ $2,515,142,000.00 | $1,515,906,000.00 |
| Revenue This Year | $5.56 | $8.85 |
| Revenue Next Year | $4.56 | $5.88 |
| P/E Ratio | $110.40 | ★ $97.84 |
| Revenue Growth | 4.78 | ★ 11.75 |
| 52 Week Low | $23.59 | $59.74 |
| 52 Week High | $49.85 | $96.74 |
| Indicator | RNG | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 56.81 |
| Support Level | $37.91 | $60.02 |
| Resistance Level | $39.66 | $71.68 |
| Average True Range (ATR) | 2.43 | 1.81 |
| MACD | -0.79 | 0.66 |
| Stochastic Oscillator | 14.64 | 80.12 |
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.